Related Experiment Videos
Diffuse interstitial fibrosis in nonasbestos pneumoconiosis--a pathological study
1Department of Pathology, Dokkyo University School of Medicine Mibu, Tochigi, Japan.
Respiration; International Review of Thoracic Diseases
|January 1, 1993
Summary
Diffuse interstitial fibrosis (DIF) affects over a quarter of non-asbestos pneumoconiosis cases, particularly older individuals with longer occupational histories. Extensive DIF significantly increases the risk of in situ malignancy.
Area of Science:
- Pulmonary Pathology
- Occupational Lung Diseases
Background:
- Nonasbestos pneumoconiosis is a group of lung diseases caused by inhaling mineral dusts.
- Diffuse interstitial fibrosis (DIF) is a common pathological finding in pneumoconiosis.
- The relationship between DIF extent and malignancy risk requires further investigation.
Purpose of the Study:
- To determine the prevalence of diffuse interstitial fibrosis (DIF) in nonasbestos pneumoconiosis.
- To investigate the association between DIF and patient demographics, occupational history, and underlying disease type.
- To evaluate the correlation between DIF extent and the development of in situ malignancy.
Main Methods:
- Retrospective analysis of 233 autopsy cases with nonasbestos pneumoconiosis.
- Pathological examination to identify and classify diffuse interstitial fibrosis (DIF).
- Statistical analysis to compare patient characteristics and outcomes based on DIF presence and extent.
Main Results:
- Diffuse interstitial fibrosis (DIF) was identified in 64 (27.5%) cases.
- Older age and longer occupational histories were associated with DIF.
- Extensive DIF, particularly in mixed dust pneumoconiosis, showed a significantly higher rate of in situ malignancy (33.3%) compared to focal disease (2.6%).
Conclusions:
- Diffuse interstitial fibrosis (DIF) is a significant finding in nonasbestos pneumoconiosis.
- The extent of DIF, especially when extensive, is a critical factor associated with increased malignancy risk.
- These findings highlight the importance of recognizing and assessing DIF in occupational lung disease for cancer risk stratification.